124 related articles for article (PubMed ID: 2959965)
1. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
Caspary L; Creutzig A; Alexander K
Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
[No Abstract] [Full Text] [Related]
2. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1987; 17():17-22. PubMed ID: 3470960
[No Abstract] [Full Text] [Related]
3. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
Thum J; Caspary L; Creutzig A; Alexander K
Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
[TBL] [Abstract][Full Text] [Related]
4. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
Herold A; Bruch HP; Hörl M; Düsel W
Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
[TBL] [Abstract][Full Text] [Related]
5. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
Creutzig A; Caspary L; Ranke C; Kiessling D; Wilkens J; Frölich J; Alexander K
Vasa; 1987; 16(2):114-8. PubMed ID: 2955602
[No Abstract] [Full Text] [Related]
6. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
[TBL] [Abstract][Full Text] [Related]
7. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
8. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
9. [Transcutaneous oxygen measurement and laser Doppler flowmetry in patients with arterial occlusive disease, chronic venous insufficiency and a combination of both diseases].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1987; 20():314-6. PubMed ID: 2962313
[No Abstract] [Full Text] [Related]
10. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
Creutzig A; Creutzig H; Alexander K
Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
[TBL] [Abstract][Full Text] [Related]
11. [Laser Doppler flowmetry in probands with healthy vessels and in patients with Fontaine stage II-IV peripheral arterial occlusive disease].
Ranft J; Peters A; Rummel S; Heidrich H
Vasa Suppl; 1987; 20():317-22. PubMed ID: 2962314
[No Abstract] [Full Text] [Related]
12. The relationship of transcutaneous PO2 and laser Doppler measurements in a human model of local arterial insufficiency.
Matsen FA; Wyss CR; Robertson CL; Oberg PA; Holloway GA
Surg Gynecol Obstet; 1984 Nov; 159(5):418-22. PubMed ID: 6495138
[TBL] [Abstract][Full Text] [Related]
13. Laser Doppler examination of peripheral microvascular reactivity.
Lerche A; Paaske WP
Surg Gynecol Obstet; 1986 Nov; 163(5):410-4. PubMed ID: 2946086
[TBL] [Abstract][Full Text] [Related]
14. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
16. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
17. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
[TBL] [Abstract][Full Text] [Related]
18. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
19. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
20. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
